| 101619-13-0 |
|
Piperazine,1-[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-4-[4-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)butyl]-, (E)- |
C24H30N6O5 |
- |
-
|
| 101619-14-1 |
|
2-Propenamide,3-(3,4-dihydroxyphenyl)-N-[3-[4-(diphenylmethoxy)-1-piperidinyl]propyl]-, (E)- |
C30H34N2O4 |
- |
-
|
| 101619-18-5 |
|
2-Propenamide,N-[3-[4-(diphenylmethoxy)-1-piperidinyl]propyl]-3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)- |
C32H38N2O5 |
- |
-
|
| 101619-19-6 |
|
Piperazine,1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-4-[3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl]-, (E)- |
C26H34N6O6 |
- |
-
|
| 101619-21-0 |
|
2,4-Pentadienamide,5-(3,4-dihydroxyphenyl)-N-[4-[4-(diphenylmethoxy)-1-piperidinyl]butyl]-,(E,E)- |
C33H38N2O4 |
- |
-
|
| 101619-23-2 |
|
2,4-Pentadienamide,N-[3-[4-(diphenylmethoxy)-1-piperidinyl]propyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)- |
C33H38N2O4 |
- |
-
|
| 101619-26-5 |
|
2-Propenamide,N-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl]-3-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-, (E)- |
C33H40ClN3O5 |
- |
-
|
| 101619-27-6 |
|
2-Thiazolidinone,3-[3-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-1-oxo-2-propenyl]-, (E)- |
C17H21NO6S |
- |
-
|
| 101619-28-7 |
|
2-Propenamide,N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-3-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-, (E)- |
C33H41N3O5 |
- |
-
|
| 101619-29-8 |
|
2-Propenamide,N-(4-aminobutyl)-3-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-,(E)- |
C18H28N2O5 |
- |
-
|
| 101619-33-4 |
|
2-Propenamide,N-[[3-(acetyloxy)-5-[(acetyloxy)methyl]-2-methyl-4-pyridinyl]methyl]-3-[3,4-bis(acetyloxy)phenyl]-, (E)- |
C25H26N2O9 |
- |
-
|
| 101619-35-6 |
|
2-Propenamide,N-(4-aminobutyl)-3-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-, (E)- |
C21H34N2O7 |
- |
-
|
| 101619-39-0 |
|
Piperazine,1-[3-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-1-oxo-2-propenyl]-4-(diphenylmethyl)-, (E)- |
C34H42N2O7 |
- |
-
|
| 101619-40-3 |
|
Acetamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-2,2,2-trifluoro- |
C21H24F3N3O |
- |
-
|
| 101619-41-4 |
|
2-Propenamide,3-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-, (E)- |
C36H47N3O7 |
- |
-
|
| 101619-42-5 |
|
2-Propenoic acid, 3-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-, (E)- |
C17H24O8 |
- |
-
|
| 101619-44-7 |
|
2-Propenamide,3-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-N-(2-hydroxyphenyl)-, (E)- |
C23H29NO8 |
- |
-
|
| 101619-46-9 |
|
2,4-Pentadienoic acid,5-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-, (E,E)- |
C16H20O6 |
- |
-
|
| 101619-49-2 |
|
2,4-Pentadienoic acid,5-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-, ethyl ester, (E,E)- |
C18H24O6 |
- |
-
|
| 101619-51-6 |
|
Piperazine,1-(diphenylmethyl)-4-[5-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-1-oxo-2,4-pentadienyl]-, (E,E)- |
C33H38N2O5 |
- |
-
|